Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
1. 系统已在2026-01-01 10:30:16对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: http://www.nejm.org/doi/10.1056/NEJMoa2505928
其他信息:
出版社: Massachusetts Medical Society
作者: Stephen J. Nicholls; Imre Pavo; Deepak L. Bhatt; John B. Buse; Stefano Del Prato; Steven E. Kahn; A. Michael Lincoff; Darren K. McGuire; Debra Miller; Michael A. Nauck; Hiroshi Nishiyama; Steven E. Nissen; Naveed Sattar; Govinda Weerakkody; Russell J. Wiese; Bernard Zinman; Sophia Zoungas; Jan Basile; Melanie J. Davies; Francesco Giorgino; Monika Kellerer; Linong Ji; Tamas Varkonyi; Venu Menon; Jonathan C. Broder; Alan Herschtal; David D’Alessio

